Recent Finacing
Recent Raise
Salubris Biotherapeutics is a clinical-stage biotechnology company developing complex biologic therapeutics—antibody fusions and ADCs—for cardiovascular, oncology, and neurodegenerative indications, with candidates in Phase 1–2 and preclinical studies.
